Cellectar Biosciences Inc (CLRB) — Cash Flow-to-Debt Ratio
Cellectar Biosciences Inc (CLRB) has a Cash Flow-to-Debt Ratio of -0.86x as of December 2025, meaning its operating cash flow of $-4.34 Million could theoretically repay -1% of its total liabilities ($5.06 Million) in one year. See CLRB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cellectar Biosciences Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Cellectar Biosciences Inc across 22 annual periods. Also explore Cellectar Biosciences Inc (CLRB) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cellectar Biosciences Inc (2004–2025)
Year-by-year debt coverage analysis for Cellectar Biosciences Inc. For market capitalisation and broader financial context, see Cellectar Biosciences Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.57x | $-23.12 Million | $5.06 Million | ▼ -7.4% |
| 2024 | -4.26x | $-47.58 Million | $11.18 Million | ▼ -239.9% |
| 2023 | -1.25x | $-32.38 Million | $25.85 Million | ▲ +40.1% |
| 2022 | -2.09x | $-25.22 Million | $12.05 Million | ▲ +61.5% |
| 2021 | -5.43x | $-22.57 Million | $4.16 Million | ▼ -50.6% |
| 2020 | -3.60x | $-13.93 Million | $3.86 Million | ▲ +1.6% |
| 2019 | -3.66x | $-11.69 Million | $3.19 Million | ▲ +42.6% |
| 2018 | -6.38x | $-11.44 Million | $1.79 Million | ▼ -22.6% |
| 2017 | -5.21x | $-11.02 Million | $2.12 Million | ▼ -12.2% |
| 2016 | -4.64x | $-8.28 Million | $1.78 Million | ▼ -236.0% |
| 2015 | -1.38x | $-8.21 Million | $5.95 Million | ▲ +58.2% |
| 2014 | -3.31x | $-8.84 Million | $2.67 Million | ▼ -84.8% |
| 2013 | -1.79x | $-9.15 Million | $5.12 Million | ▲ +64.1% |
| 2012 | -4.99x | $-6.59 Million | $1.32 Million | ▲ +9.6% |
| 2011 | -5.52x | $-5.97 Million | $1.08 Million | ▲ +11.3% |
| 2010 | -6.22x | $-7.80 Million | $1.25 Million | ▼ -1999.9% |
| 2009 | -0.30x | $-10.62 Million | $35.83 Million | ▲ +87.9% |
| 2008 | -2.46x | $-17.33 Million | $7.05 Million | ▼ -209.9% |
| 2007 | -0.79x | $-13.47 Million | $16.98 Million | ▲ +83.9% |
| 2006 | -4.93x | $-6.47 Million | $1.31 Million | ▲ +55.4% |
| 2005 | -11.05x | $-2.40 Million | $217.16K | ▼ -12553.9% |
| 2004 | -0.09x | $-389.18K | $4.46 Million | — |